News | Quality Assurance (QA) | September 16, 2019

Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

Company will highlight new tools for workflow automation and emergent techniques

Sun Nuclear Presents Portfolio of Independent Radiotherapy QA Solutions at ASTRO 2019

The PlanCheck module now part of SunCheck, automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent.

September 16, 2019 — At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear Corp. will present novel advancements in radiation oncology quality management.

For the SunCheck Quality Management Platform, Sun Nuclear introduces PlanCheck. This new module within the SunCheck Patient workflow automates plan quality checks, validates treatment plans against requirements, and automatically assesses plan performance versus intent. At ASTRO 2019, Sun Nuclear will also highlight SunCheck's expanded direct device integration, plus support for Varian Halcyon System secondary dose calculations, pre-treatment quality assurance (QA) and in-vivo monitoring.

Sun Nuclear will also introduce new Precision Laser Systems for positron emission tomography/computed tomography (PET/CT) simulation, magnetic resonance (MR) simulation, MR-guided radiotherapy (RT) and linear accelerator (linac)-based RT. Redesigned to better fit clinical workflows, CT SIM+ and MICRO+ laser systems offer high precision and accuracy at the patient, with what the company calls unmatched reliability, laser line definition and laser line length. Compatible with all major third-party systems, CT SIM+ software provides automation for enhanced patient focus.  

Beyond workflow automation support, Sun Nuclear enables adoption of emergent treatment techniques, including stereotactic radiosurgery (SRS) and MR-guided radiation therapy (MRgRT).

Enhancing the Sun Nuclear SRS QA portfolio is the introduction of the MultiMet-WL Cube. The device quantifies the margin of error for off-axis SRS targets, measuring error margins for single-isocenter multiple metastases treatments. Further supporting SRS programs are advancements with SRS MapCheck, including support for the Accuray CyberKnife System and vertex fields, including HyperArc. 

Sun Nuclear addresses the challenges of MRgRT with a suite of solutions, including ArcCheck-MR and IC Profiler-MR. Available soon and on display at ASTRO, Daily QA-MR will become the first commercially available daily QA system for MR-linacs.

For more information: www.sunnuclear.com

Related Content

An example of the MRI scans showing long-term and short-term survival indications. #MRI

An example of the MRI scans showing long-term and short-term survival indications. Image courtesy of Case Western Reserve University

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — ...
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Nuclear imaging equipment growth in 2020
News | Nuclear Imaging | February 14, 2020
February 14, 2020 — The nuclear imaging equipment
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26 percent of patients undergoing pulmonary resection for non-small-cell lung cancer (NSCLC)

A Purdue discovery being developed by On Target Laboratories Inc., illuminates lung cancer cells on a patient during surgery. The “fluorescent markers” help medical professionals identify and remove cancer cells during surgery and is shown to improve outcomes. The technology is beginning Phase 3 clinical trials. (Photo provided by On Target)

News | Molecular Imaging | February 06, 2020
February 6, 2020 — ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.